Medtronic(US:MDT) ZACKS·2026-01-30 23:51Company Performance - Medtronic's stock increased by 1.94% to $102.96, outperforming the S&P 500, which fell by 0.43% [1] - Over the past month, Medtronic shares gained 5.14%, while the Medical sector declined by 2.36% and the S&P 500 rose by 0.89% [1] Upcoming Earnings - Medtronic is set to release its earnings report on February 17, 2026, with an expected EPS of $1.33, reflecting a 4.32% decrease from the same quarter last year [2] - Revenue is anticipated to be $8.9 billion, indicating a 7.29% increase compared to the previous year [2] Annual Estimates - For the annual period, Zacks Consensus Estimates project earnings of $5.64 per share and revenue of $36.04 billion, representing increases of 2.73% and 7.46%, respectively, from last year [3] Analyst Sentiment - Recent changes to analyst estimates for Medtronic are crucial, as positive revisions indicate optimism about the company's business and profitability [3][4] - The Zacks Rank system, which evaluates estimate changes, currently ranks Medtronic at 4 (Sell) [5] Valuation Metrics - Medtronic has a Forward P/E ratio of 17.9, which is lower than the industry average of 19.03 [6] - The company's PEG ratio stands at 2.66, compared to the industry average PEG ratio of 1.69 [6] Industry Context - The Medical - Products industry, which includes Medtronic, has a Zacks Industry Rank of 158, placing it in the bottom 36% of over 250 industries [7] - The top 50% rated industries tend to outperform the bottom half by a factor of 2 to 1 [7]